{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T00:24:57Z","timestamp":1793924697947,"version":"4.8.0"},"reference-count":24,"publisher":"Georg Thieme Verlag KG","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Clin Endocrinol Diabetes"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>We evaluated long-term trends in pharmacotherapy costs and cardiovascular\n                        risk factor target achievement among people with type 2 diabetes attending\n                        tertiary diabetes centres in Greece.<\/jats:p>\n                  <jats:p>This periodic, multicenter, cross-sectional study analysed data from 4,963\n                        people with type 2 diabetes attending three diabetes centres at specific\n                        time points: 1998, 2006, 2012, 2018, and 2024. We compared glycated\n                        haemoglobin, systolic blood pressure, low-density lipoprotein cholesterol,\n                        and body mass index and the achievement of individual cardiovascular risk\n                        factor targets (glycated haemoglobin: &lt;\u20097%, systolic blood pressure:\n                        &lt;\u2009140 mm Hg, and low-density lipoprotein cholesterol: &lt;\u2009100 mg\/dL) and\n                        all three targets simultaneously. Annual pharmacotherapy costs were compared\n                        using inflation-adjusted values.<\/jats:p>\n                  <jats:p>Simultaneous achievement of all three cardiovascular risk factor targets\n                        increased from 0.6% in 1998 to 29.1% in 2024. Individual target achievements\n                        improved: glycated haemoglobin from 29.4 to 58.6%, systolic blood pressure\n                        from 45.3 to 62.5%, and low-density lipoprotein cholesterol from 6.3 to\n                        73.4%. Mean low-density lipoprotein cholesterol showed the greatest\n                        reduction from 128.4 to 79.0 mg\/dL. Median body mass index increased until\n                        2018 and then declined in 2024. Total pharmacotherapy costs per patient rose\n                        from \u20ac341 in 1998 to \u20ac1,609 in 2024, primarily due to glucose-lowering\n                        therapies (\u20ac167\u2013\u20ac1,257).<\/jats:p>\n                  <jats:p>Over 26 years, people with type 2 diabetes attending tertiary diabetes\n                        centres in Greece demonstrated improvements in cardiovascular risk factor\n                        target achievement, alongside rising pharmacotherapy costs, primarily driven\n                        by glucose-lowering therapies.<\/jats:p>","DOI":"10.1055\/a-2978-1630","type":"journal-article","created":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:02:42Z","timestamp":1791849762000},"source":"Crossref","is-referenced-by-count":0,"title":["Trends in Inflation-Adjusted Pharmacotherapy Costs and Cardiovascular\n                    Risk Factor Management in Type 2 Diabetes: A 26-Year Study from Tertiary\n                    Diabetes Cen\u200b\u200b\u200b\u200btres in Greece \u200b\u200b\u200b"],"prefix":"10.1055","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8870-6475","authenticated-orcid":false,"given":"Georgios","family":"Karamanakos","sequence":"additional","affiliation":[{"name":"National and Kapodistrian University of Athens Faculty\n                    of Medicine, Attica, Greece","place":["Athens"],"department":["Diabetes Centre, First Department of Propaedeutic Internal Medicine,\n                    Laiko General Hospital"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasia","family":"Papazafiropoulou","sequence":"additional","affiliation":[{"name":"Tzaneio General Hospital of Piraeus, Greece","place":["Piraeus"],"department":["First Department of Internal Medicine and Diabetes Centre"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasios","family":"Koutsovasilis","sequence":"additional","affiliation":[{"name":"General Hospital of Nikaia-Piraeus, Greece","place":["Piraeus"],"department":["First Department of Internal Medicine and Diabetes Centre"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kleomenis","family":"Salapatas","sequence":"additional","affiliation":[{"name":"National and Kapodistrian University of Athens Faculty\n                    of Medicine, Attica, Greece","place":["Athens"],"department":["Diabetes Centre, First Department of Propaedeutic Internal Medicine,\n                    Laiko General Hospital"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Vroucho","sequence":"additional","affiliation":[{"name":"Tzaneio General Hospital of Piraeus, Greece","place":["Piraeus"],"department":["First Department of Internal Medicine and Diabetes Centre"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasiliki","family":"Chatzivasiloglou","sequence":"additional","affiliation":[{"name":"General Hospital of Nikaia-Piraeus, Greece","place":["Piraeus"],"department":["First Department of Internal Medicine and Diabetes Centre"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Manganas","sequence":"additional","affiliation":[{"name":"National and Kapodistrian University of Athens Faculty\n                    of Medicine, Attica, Greece","place":["Athens"],"department":["Diabetes Centre, First Department of Propaedeutic Internal Medicine,\n                    Laiko General Hospital"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Persefoni","family":"Michou","sequence":"additional","affiliation":[{"name":"Tzaneio General Hospital of Piraeus, Greece","place":["Piraeus"],"department":["First Department of Internal Medicine and Diabetes Centre"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andriana","family":"Konstantelou","sequence":"additional","affiliation":[{"name":"General Hospital of Nikaia-Piraeus, Greece","place":["Piraeus"],"department":["First Department of Internal Medicine and Diabetes Centre"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Garbi","sequence":"additional","affiliation":[{"name":"National and Kapodistrian University of Athens Faculty\n                    of Medicine, Attica, Greece","place":["Athens"],"department":["Diabetes Centre, First Department of Propaedeutic Internal Medicine,\n                    Laiko General Hospital"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholaos","family":"Tentolouris","sequence":"additional","affiliation":[{"name":"National and Kapodistrian University of Athens Faculty\n                    of Medicine, Attica, Greece","place":["Athens"],"department":["Diabetes Centre, First Department of Propaedeutic Internal Medicine,\n                    Laiko General Hospital"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stavros","family":"Liatis","sequence":"additional","affiliation":[{"name":"National and Kapodistrian University of Athens Faculty\n                    of Medicine, Attica, Greece","place":["Athens"],"department":["Diabetes Centre, First Department of Propaedeutic Internal Medicine,\n                    Laiko General Hospital"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2026,11,5]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"100909","DOI":"10.1016\/J.LANEPE.2024.100909","article-title":"Trends in cause-specific mortality among people with type 2 and type 1 diabetes\n                    from 2002 to 2019: a Danish population-based study","volume":"41","author":"T Laurberg","year":"2024","journal-title":"Lancet Reg Health Eur"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S2213-8587(20)30431-9","article-title":"Trends in predominant causes of death in individuals with and without diabetes\n                    in England from 2001 to 2018: an epidemiological analysis of linked primary care\n                    records","volume":"9","author":"J Pearson-Stuttard","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"278","DOI":"10.7326\/M20-0864","article-title":"Comparative effectiveness of glucose-lowering drugs for type 2 diabetes: a\n                    systematic review and network meta-analysis","volume":"173","author":"A Tsapas","year":"2020","journal-title":"Ann Intern Med"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.18553\/JMCP.2025.31.10.1029","article-title":"Patterns and costs associated with glucagon-like peptide-1 receptor agonist use\n                    in US adults with type 2 diabetes","volume":"31","author":"J Wu","year":"2025","journal-title":"J Manag Care Spec Pharm"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1007\/S00125-016-4065-6","article-title":"Years of life gained by multifactorial intervention in patients with type 2\n                    diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2\n                    randomised trial","volume":"59","author":"P G\u00e6de","year":"2016","journal-title":"Diabetologia"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1056\/NEJMOA1800256","article-title":"Risk factors, mortality, and cardiovascular outcomes in patients with type 2\n                    diabetes","volume":"379","author":"A Rawshani","year":"2018","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1111\/DME.14159","article-title":"Variation in the achievement of HbA1c, blood pressure and LDL\n                    cholesterol targets in type 2 diabetes in general practice and characteristics\n                    associated with risk factor control","volume":"37","author":"A Bakke","year":"2020","journal-title":"Diabet Med"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"26","DOI":"10.2337\/DCI23-0085","article-title":"Economic Costs of Diabetes in the U.S. in 2022","volume":"47","author":"E D Parker","year":"2024","journal-title":"Diabetes Care"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"963","DOI":"10.2337\/DC17-1962","article-title":"Global economic burden of diabetes in adults: projections from 2015 to 2030","volume":"41","author":"C Bommer","year":"2018","journal-title":"Diabetes Care"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1055\/S-0029-1225338","article-title":"Trends in the management of type 2 diabetes and its prescription drug costs in\n                    Greece (1998 & 2006)","volume":"117","author":"S Liatis","year":"2009","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1472-6823-14-23","article-title":"Management of type 2 diabetes and its prescription drug cost before and during\n                    the economic crisis in Greece: an observational study","volume":"14","author":"S Liatis","year":"2014","journal-title":"BMC Endocr Disord"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"108095","DOI":"10.1016\/j.diabres.2020.108095","article-title":"Twenty-year trends in the prescription costs of type 2 diabetes: Real world data\n                    and empirical analysis in Greece","volume":"162","author":"K Athanasakis","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/S2213-8587(25)00299-2","article-title":"11th edition of the IDF Diabetes Atlas: global, regional, and national diabetes\n                    prevalence estimates for 2024 and projections for 2050","volume":"14","author":"I Genitsaridi","year":"2026","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/S00125-005-0048-8","article-title":"Patient and provider perceptions of care for diabetes: results of the\n                    cross-national DAWN Study","volume":"49","author":"M Peyrot","year":"2006","journal-title":"Diabetologia"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1016\/S0735-1097(02)02529-9","article-title":"Physician attitudes and practices and patient awareness of the cardiovascular\n                    complications of diabetes","volume":"40","author":"CN B Merz","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/J.PCD.2025.06.008","article-title":"Trends in metabolic risk factors control among adults with type 2 diabetes: a\n                    comparative study of 2018 and 2021","volume":"19","author":"F Baygi","year":"2025","journal-title":"Prim Care Diabetes"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"112154","DOI":"10.1016\/J.DIABRES.2025.112154","article-title":"National trends in per-capita medical expenditures among U.S. adults with\n                    diabetes, 2000\u20132022","volume":"223","author":"S Tang","year":"2025","journal-title":"Diabetes Res Clin Pract"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1080\/14737167.2018.1513790","article-title":"Cost analysis of type 2 diabetes mellitus treatment in economically developed\n                    countries","volume":"19","author":"S Ramzan","year":"2019","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1186\/S12913-018-3772-8","article-title":"Cost-of-illness of type 2 diabetes mellitus in low and lower-middle income\n                    countries: a systematic review","volume":"18","author":"A Afroz","year":"2018","journal-title":"BMC Health Serv Res"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"108072","DOI":"10.1016\/j.diabres.2020.108072","article-title":"Global and regional estimates and projections of diabetes-related health\n                    expenditure: results from the International Diabetes Federation Diabetes Atlas,\n                    9th edition","volume":"162","author":"R Williams","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1007\/S00125-023-05950-3","article-title":"Health and economic impact of improved glucose, blood pressure and lipid control\n                    among German adults with type 2 diabetes: a modelling study","volume":"66","author":"M Fan","year":"2023","journal-title":"Diabetologia"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1080\/13696998.2025.2604454","article-title":"Clinical benefits and cost saving of achieving composite treatment targets for\n                    type 2 diabetes \u2013 a modeling study","volume":"29","author":"S Si","year":"2026","journal-title":"J Med Econ"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"113001","DOI":"10.1016\/j.diabres.2025.113001","article-title":"Global guideline recommended target achievements in glycaemic, blood pressure,\n                    and lipid control in type 2 diabetes: an updated meta-analysis of 1,618,972\n                    participants","volume":"230","author":"G Kacha","year":"2025","journal-title":"Diabetes Res Clin Pract"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"e006400","DOI":"10.1161\/JAHA.117.006400","article-title":"Effect of multifactorial treatment targets and relative importance of hemoglobin\n                    A1c, blood pressure, and low-density lipoprotein-cholesterol on cardiovascular\n                    diseases in Chinese primary care patients with type 2 diabetes mellitus: a\n                    population-based retrospective cohort study","volume":"6","author":"EY F Wan","year":"2017","journal-title":"J Am Heart Assoc"}],"container-title":["Experimental and Clinical Endocrinology &amp; Diabetes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2978-1630.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T23:37:32Z","timestamp":1793921852000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2978-1630"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,12]]},"references-count":24,"URL":"https:\/\/doi.org\/10.1055\/a-2978-1630","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0947-7349","1439-3646"],"issn-type":[{"value":"0947-7349","type":"print"},{"value":"1439-3646","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10,12]]},"published":{"date-parts":[[2026,10,12]]}}}